Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

Also called NCT05940220

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05940220
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05940220. Randomized; double masking; primary purpose treatment. Start 2023-12-30 (anticipated); primary completion 2025-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure
Condition
Heart Failure
Intervention (Other)
Acetazolamide
Intervention (Other)
placebo
Lead sponsor
Tehran University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct05940220
Content hash
62344495891ad8d6e9c49f3988d8f52c465734c49dc7e6ac19045f52752b385d